checkAd

    Sosei Group  309  0 Kommentare Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office - Seite 2

    1. New location

    9-7-2 Akasaka Minato-ku
    Tokyo 107-0052
    Japan

    1. Date of change

    1 April 2024 (planned)
    * The change is subject to the approval of a partial amendment to the Articles of Incorporation at the Ordinary General Meeting of Shareholders.

    1. Merger of wholly owned consolidated subsidiaries
    1. Purpose of the Merger

    Since the acquisition of IPJ in July 2023, the Company has been pursuing integration synergies and decided to merge IPJ and Sosei Co. Ltd to accelerate business integration and enhance operating efficiencies.

    1. Schedule of the Merger
    15 February 2024 Approval of the Merger Agreement by the Board of Directors (the Company)
    19 February 2024 Approval of the Merger Agreement by the Board of Directors (Sosei Co. Ltd)
    20 February 2024 Approval of the Merger Agreement by the Board of Directors (IPJ)
    20 February 2024 (planned) Execution of the Merger Agreement by the merging companies
    27 March 2024 (planned) Approval of the Merger Agreement at the Meeting of Shareholders (the merging companies)
    1 April 2024 (planned) Effective date of the Merger (Merger date)


    1. Merger format

    The Merger will be an absorption-type merger with IPJ as the surviving company and Sosei Co. Ltd. as the non-surviving company.

    1. Partial amendments to the Articles of Incorporation
    1. Reason for the amendments

    This is to amend Article 1 (Corporate Name) and Article 3 (Head Office) of the current Articles of Incorporation to make the change of corporate name of the Company mentioned in 1 and the change of the location of the Company mentioned in 2 above. This is also to amend the number of directors specified in Article 19 of the existing Articles of Incorporation from not more than ten (10) to not more than twelve (12) directors to allow for future flexibility to enhance the supervisory function of the Board as the Company grows.

    1. Details of amendments

    The following table shows the current Articles of Incorporation and proposed Articles of Incorporation after amendments.

    Current Articles of Incorporation Proposed amendments
    CHAPTER 1 GENERAL RULES
    (Corporate Name)
    Article 1.  The name of the Company shall be “Sosei Group Kabushiki Kaisha,” and shall be “Sosei Group Corporation” in English.

     
    Seite 2 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Sosei Group Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office - Seite 2 Tokyo, Japan and Cambridge, UK, 16 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), today announces that at a meeting held on 15 February 2024, its Board of Directors resolved to change the corporate names of …

    Schreibe Deinen Kommentar

    Disclaimer